Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
Convatec is seeking Wound Care Sales Managers based in Mumbai to expand our wound care business. You will travel within the region, generate leads, and educate clients through product demonstrations and trade shows.
Ideal candidates have a proven wound sales track record, strong relationship-building skills, and the ability to manage multiple accounts while meeting targets and contributing to marketing initiatives.
We are seeking accomplished professionals to join our dynamic team as Wound Care Sales Managers based in Mumbai. This is a unique opportunity to contribute to the expansion of our wound care business and make a significant impact in the healthcare industry.
The successful candidates will be disciplined professionals with a proven track record in wound sales. You will be involved with frequent travel in your region, generating new sales leads, and effectively communicating with team members in the field.
At Convatec, we’re pioneering trusted medical solutions to improve the lives we touch.
Convatec provides equal employment opportunities for all current employees and applicants for employment. This policy means that no one will be discriminated against because of race, religion, creed, color, national origin, nationality, citizenship, ancestry, sex, age, marital status, physical or mental disability, affectional or sexual orientation, gender identity, military or veteran status, genetic predisposing characteristics or any other basis prohibited by law.
Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit: http://www.convatecgroup.com.